Definitions
Sorry, no definitions found. You may find more data at activiomics.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Activiomics.
Examples
-
The technology has been developed by scientists at Barts and The London School of Medicine and Dentistry at Queen Mary University of London, and is being sold through their spin-out company Activiomics, which has agreed to deploy the innovation commercially with GlaxoSmithKline (GSK).
The Engineer - News 2010
-
Mark Warne, interim chief executive of Activiomics, said that the technology, known as TIQUAS (Targeted Quantification of Cell Signalling), works by using a protease enzyme to break down a cell or tissue extract into peptide fragments.
The Engineer - News 2010
-
The technology has been developed by scientists at Barts and The London School of Medicine and Dentistry at Queen Mary University of London, and is being sold through their spin-out company Activiomics, which has agreed to deploy the innovation commercially with GlaxoSmithKline (GSK).
The Engineer - News 2010
-
The technology has been developed by scientists at Barts and The London School of Medicine and Dentistry at Queen Mary University of London, and is being sold through their spin-out company Activiomics, which has agreed to deploy the innovation commercially with GlaxoSmithKline (GSK).
The Engineer - News 2010
-
Mark Warne, interim chief executive of Activiomics, said that the technology, known as TIQUAS (Targeted Quantification of Cell Signalling), works by using a protease enzyme to break down a cell or tissue extract into peptide fragments.
The Engineer - News 2010
-
Mark Warne, interim chief executive of Activiomics, said that the technology, known as TIQUAS (Targeted Quantification of Cell Signalling), works by using a protease enzyme to break down a cell or tissue extract into peptide fragments.
The Engineer - News 2010
-
The technology has been developed by scientists at Barts and The London School of Medicine and Dentistry at Queen Mary University of London, and is being sold through their spin-out company Activiomics, which has agreed to deploy the innovation commercially with GlaxoSmithKline (GSK).
The Engineer - News 2010
-
Mark Warne, interim chief executive of Activiomics, said that the technology, known as TIQUAS (Targeted Quantification of Cell Signalling), works by using a protease enzyme to break down a cell or tissue extract into peptide fragments.
The Engineer - News 2010
-
The technology has been developed by scientists at Barts and The London School of Medicine and Dentistry at Queen Mary University of London, and is being sold through their spin-out company Activiomics, which has agreed to deploy the innovation commercially with GlaxoSmithKline (GSK).
The Engineer - News 2010
-
Mark Warne, interim chief executive of Activiomics, said that the technology, known as TIQUAS (Targeted Quantification of Cell Signalling), works by using a protease enzyme to break down a cell or tissue extract into peptide fragments.
The Engineer - News 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.